These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

729 related items for PubMed ID: 7503188

  • 21. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M.
    Cancer; 1996 Jul 15; 78(2):287-93. PubMed ID: 8674005
    [Abstract] [Full Text] [Related]

  • 22. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K, Krishnamurthy J, Feng J, Nakajima T, Tsuchida N, Shanmugam G.
    Int J Oncol; 2000 Nov 15; 17(5):1031-5. PubMed ID: 11029509
    [Abstract] [Full Text] [Related]

  • 23. Carcinoma of the vulva: HPV and p53 mutations.
    Lee YY, Wilczynski SP, Chumakov A, Chih D, Koeffler HP.
    Oncogene; 1994 Jun 15; 9(6):1655-9. PubMed ID: 8183560
    [Abstract] [Full Text] [Related]

  • 24. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
    Nylander K, Nilsson P, Mehle C, Roos G.
    Br J Cancer; 1995 Apr 15; 71(4):826-30. PubMed ID: 7710950
    [Abstract] [Full Text] [Related]

  • 25. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K, Regauer S.
    Gynecol Oncol; 2017 Aug 15; 146(2):314-318. PubMed ID: 28527674
    [Abstract] [Full Text] [Related]

  • 26. Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines.
    Min BM, Baek JH, Shin KH, Gujuluva CN, Cherrick HM, Park NH.
    Eur J Cancer B Oral Oncol; 1994 Sep 15; 30B(5):338-45. PubMed ID: 7703804
    [Abstract] [Full Text] [Related]

  • 27. p53 protein accumulation and gene mutations in human glioma cell lines.
    Anker L, Ohgaki H, Ludeke BI, Herrmann HD, Kleihues P, Westphal M.
    Int J Cancer; 1993 Dec 02; 55(6):982-7. PubMed ID: 8253536
    [Abstract] [Full Text] [Related]

  • 28. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
    Kreimer-Erlacher H, Seidl H, Bäck B, Kerl H, Wolf P.
    Photochem Photobiol; 2001 Aug 02; 74(2):323-30. PubMed ID: 11547572
    [Abstract] [Full Text] [Related]

  • 29. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma.
    Sakai E, Rikimaru K, Ueda M, Matsumoto Y, Ishii N, Enomoto S, Yamamoto H, Tsuchida N.
    Int J Cancer; 1992 Dec 02; 52(6):867-72. PubMed ID: 1459726
    [Abstract] [Full Text] [Related]

  • 30. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC.
    Carcinogenesis; 1993 May 02; 14(5):987-92. PubMed ID: 8389256
    [Abstract] [Full Text] [Related]

  • 31. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY, Lin SR, Hsieh JS, Hsu CH, Huang YS, Huang TJ.
    Anticancer Res; 2001 May 02; 21(1B):513-20. PubMed ID: 11299797
    [Abstract] [Full Text] [Related]

  • 32. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.
    Warren W, Biggs PJ, el-Baz M, Ghoneim MA, Stratton MR, Venitt S.
    Carcinogenesis; 1995 May 02; 16(5):1181-9. PubMed ID: 7767983
    [Abstract] [Full Text] [Related]

  • 33. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa.
    Vos M, Adams CH, Victor TC, van Helden PD.
    Cancer Genet Cytogenet; 2003 Jan 01; 140(1):23-30. PubMed ID: 12550754
    [Abstract] [Full Text] [Related]

  • 34. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
    Lung ML, Chan WC, Zong YS, Tang CM, Fok CL, Wong KT, Chan LK, Lau KW.
    Cancer Epidemiol Biomarkers Prev; 1996 Apr 01; 5(4):277-84. PubMed ID: 8722219
    [Abstract] [Full Text] [Related]

  • 35. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB, LaBate M, Liu F, Osterndorff E.
    Mol Carcinog; 1996 Aug 01; 16(4):197-202. PubMed ID: 8784462
    [Abstract] [Full Text] [Related]

  • 36. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.
    Reiss M, Brash DE, Muñoz-Antonia T, Simon JA, Ziegler A, Vellucci VF, Zhou ZL.
    Oncol Res; 1992 Aug 01; 4(8-9):349-57. PubMed ID: 1486218
    [Abstract] [Full Text] [Related]

  • 37. Frequent association of p53 gene mutation in invasive bladder cancer.
    Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T, Terada M.
    Cancer Res; 1992 Mar 15; 52(6):1393-8. PubMed ID: 1540947
    [Abstract] [Full Text] [Related]

  • 38. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
    Chang F, Syrjänen S, Tervahauta A, Kurvinen K, Wang L, Syrjänen K.
    Br J Cancer; 1994 Aug 15; 70(2):346-51. PubMed ID: 8054284
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.